| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
421,671 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
166,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$81,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ehlinger Robert |
VP and CIO |
• – – |
2018-03-31 |
4 |
A |
$13.64 |
$7,229 |
D/D |
530 |
23,509 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2018-03-31 |
4 |
A |
$13.64 |
$5,538 |
D/D |
406 |
19,247 |
|
- |
|
| Abt John |
Vice President of Quality |
• – – |
2018-03-30 |
4 |
D |
$16.05 |
$4,382 |
D/D |
(273) |
7,943 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2018-01-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
500,000 |
3,671,269 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2018-01-09 |
4 |
AS |
$25.01 |
$250,100 |
D/D |
(10,000) |
4,171,269 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2018-01-01 |
4 |
A |
$13.64 |
$14 |
D/D |
1 |
5,198 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2017-12-31 |
4 |
A |
$17.43 |
$10,772 |
D/D |
618 |
18,841 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2017-12-13 |
4 |
S |
$30.00 |
$5,520 |
D/D |
(184) |
4,181,269 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2017-12-05 |
4 |
AS |
$30.05 |
$261,916 |
D/D |
(8,716) |
4,181,453 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2017-12-04 |
4 |
AS |
$30.01 |
$33,011 |
D/D |
(1,100) |
4,190,169 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2017-12-01 |
4 |
AS |
$26.88 |
$268,800 |
D/D |
(10,000) |
4,191,269 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-11-27 |
4 |
S |
$27.45 |
$15,866 |
D/D |
(578) |
586,038 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-11-24 |
4 |
S |
$26.75 |
$1,337,500 |
D/D |
(50,000) |
586,616 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-11-22 |
4 |
S |
$25.50 |
$1,071,000 |
D/D |
(42,000) |
636,616 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2017-11-09 |
4 |
D |
$24.70 |
$7,509 |
D/D |
(304) |
38,928 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2017-11-09 |
4 |
D |
$24.70 |
$9,065 |
D/D |
(367) |
22,979 |
|
- |
|
| Abt John |
Vice President of Quality |
• – – |
2017-11-09 |
4 |
D |
$24.70 |
$7,509 |
D/D |
(304) |
8,216 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2017-11-09 |
4 |
D |
$24.70 |
$5,854 |
D/D |
(237) |
5,197 |
|
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2017-11-09 |
4 |
D |
$24.70 |
$6,052 |
D/D |
(245) |
18,458 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-11-09 |
4 |
D |
$24.70 |
$9,510 |
D/D |
(385) |
678,616 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-11-08 |
4 |
S |
$25.20 |
$187,034 |
D/D |
(7,422) |
679,001 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2017-11-08 |
4 |
AS |
$25.03 |
$245,294 |
D/D |
(9,800) |
4,201,269 |
|
- |
|
| Farber David |
10% Owner |
– – • |
2017-11-07 |
4 |
AS |
$25.00 |
$5,000 |
D/D |
(200) |
4,211,069 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2017-09-30 |
4 |
A |
$15.68 |
$5,880 |
D/D |
375 |
23,346 |
|
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2017-09-30 |
4 |
A |
$15.68 |
$1,599 |
D/D |
102 |
18,703 |
|
- |
|
762 Records found
|
|
Page 11 of 31 |
|
|
